Expand GOSS Menu
GOSS MENU

GOSS Latest Press Releases

-- January 8, 2026 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM

-- December 9, 2025 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM

-- November 24, 2025 --

Gossamer Bio to Participate in Upcoming Investor Conferences Business Wire 4:01 PM

-- November 7, 2025 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM
Gossamer Bio to Participate in Upcoming Investor Conferences Business Wire 7:31 AM

-- November 5, 2025 --

Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update Business Wire 4:01 PM

-- October 22, 2025 --

Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream Globe Newswire 7:00 AM

-- October 21, 2025 --

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream. Globe Newswire 7:00 AM

-- September 25, 2025 --

Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital PRNewswire 7:41 AM
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On-Demand Vardenafil for Pulmonary Hypertension Business Wire 7:31 AM

-- September 22, 2025 --

Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025 Business Wire 7:31 AM

-- September 10, 2025 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM
Market Data Delayed 15 Minutes